Strength
30 mg/1
Manufacturer
Daiichi Sankyo Inc.NDC
65597020230
Classification
Brand
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
4/22/2026
Active Ingredients
EDOXABAN TOSYLATEApproval Type
New Drug (NDA)
FDA Application
NDA206316On Market Since
1/12/2015
Pharmacological Classes
Factor Xa Inhibitor
Factor Xa Inhibitors
Related Drugs
Same classification
XARELTO 1 MG/ML SUSPENSION
Brand
50458057501•Janssen Pharmaceuticals Inc.
$3.7634
per ML
ELIQUIS 2.5 MG TABLET
Brand
00003089321•E.R. Squibb & Sons, L.L.C.
$5.5232
per EA
ELIQUIS 2.5 MG TABLET
Brand
00003089331•E.R. Squibb & Sons, L.L.C.
$5.5232
per EA
ELIQUIS 5 MG TABLET
Brand
00003089421•E.R. Squibb & Sons, L.L.C.
$5.5265
per EA
ELIQUIS 5 MG TABLET
Brand
00003089431•E.R. Squibb & Sons, L.L.C.
$5.5265
per EA
ELIQUIS 5 MG TABLET
Brand
00003089470•E.R. Squibb & Sons, L.L.C.
$5.5265
per EA
XARELTO 2.5 MG TABLET
Brand
50458057710•Janssen Pharmaceuticals Inc.
$9.7866
per EA
XARELTO 2.5 MG TABLET
Brand
50458057718•Janssen Pharmaceuticals Inc.
$9.7866
per EA
XARELTO 2.5 MG TABLET
Brand
50458057760•Janssen Pharmaceuticals Inc.
$9.7866
per EA
XARELTO 10 MG TABLET
Brand
50458058010•Janssen Pharmaceuticals Inc.
$19.5380
per EA